167 related articles for article (PubMed ID: 37885829)
1. "TO BE OR NOT TO BE" GWAS Ends the Controversy about the DRD2 Gene as a Determinant of Reward Deficiency Syndrome (RDS).
Blum K; Thanos PK; Hanna C; Gold MS; Baron D; Elman I
Psychol Res Behav Manag; 2023; 16():4287-4291. PubMed ID: 37885829
[TBL] [Abstract][Full Text] [Related]
2. Evidence for the
Blum K; Bowirrat A; Elman I; Baron D; Thanos PK; Gold MS; Hanna C; Makale MT; Sunder K; Jafari N; Zeine F; Murphy KT; Makale M; Badgaiyan RD
Clin Exp Psychol; 2023 Jun; 9(4):8-11. PubMed ID: 37560184
[TBL] [Abstract][Full Text] [Related]
3. Do dopaminergic gene polymorphisms affect mesolimbic reward activation of music listening response? Therapeutic impact on Reward Deficiency Syndrome (RDS).
Blum K; Chen TJ; Chen AL; Madigan M; Downs BW; Waite RL; Braverman ER; Kerner M; Bowirrat A; Giordano J; Henshaw H; Gold MS
Med Hypotheses; 2010 Mar; 74(3):513-20. PubMed ID: 19914781
[TBL] [Abstract][Full Text] [Related]
4. Statistical Validation of Risk Alleles in Genetic Addiction Risk Severity (GARS) Test: Early Identification of Risk for Alcohol Use Disorder (AUD) in 74,566 Case-Control Subjects.
Blum K; Han D; Gupta A; Baron D; Braverman ER; Dennen CA; Kazmi S; Llanos-Gomez L; Badgaiyan RD; Elman I; Thanos PK; Downs BW; Bagchi D; Gondre-Lewis MC; Gold MS; Bowirrat A
J Pers Med; 2022 Aug; 12(9):. PubMed ID: 36143170
[TBL] [Abstract][Full Text] [Related]
5. Genetic Addiction Risk and Psychological Profiling Analyses for "Preaddiction" Severity Index.
Blum K; Han D; Bowirrat A; Downs BW; Bagchi D; Thanos PK; Baron D; Braverman ER; Dennen CA; Gupta A; Elman I; Badgaiyan RD; Llanos-Gomez L; Khalsa J; Barh D; McLaughlin T; Gold MS
J Pers Med; 2022 Oct; 12(11):. PubMed ID: 36579510
[TBL] [Abstract][Full Text] [Related]
6. In Search of Reward Deficiency Syndrome (RDS)-free Controls: The "Holy Grail" in Genetic Addiction Risk Testing.
Blum K; Baron D; Lott L; Ponce JV; Siwicki D; Boyett B; Steinberg B; Modestino EJ; Fried L; Hauser M; Simpatico T; Downs BW; McLaughlin T; Hajela R; Badgaiyan RD
Curr Psychopharmacol; 2020; 9(1):7-21. PubMed ID: 32432025
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the Association of D2 Dopamine Receptor Gene and Reported Allele Frequencies With Alcohol Use Disorders: A Systematic Review and Meta-analysis.
Jung Y; Montel RA; Shen PH; Mash DC; Goldman D
JAMA Netw Open; 2019 Nov; 2(11):e1914940. PubMed ID: 31702801
[TBL] [Abstract][Full Text] [Related]
8. Acute intravenous synaptamine complex variant KB220™ "normalizes" neurological dysregulation in patients during protracted abstinence from alcohol and opiates as observed using quantitative electroencephalographic and genetic analysis for reward polymorphisms: part 1, pilot study with 2 case reports.
Miller DK; Bowirrat A; Manka M; Miller M; Stokes S; Manka D; Allen C; Gant C; Downs BW; Smolen A; Stevens E; Yeldandi S; Blum K
Postgrad Med; 2010 Nov; 122(6):188-213. PubMed ID: 21084795
[TBL] [Abstract][Full Text] [Related]
9. Increased prevalence of the Taq I A1 allele of the dopamine receptor gene (DRD2) in obesity with comorbid substance use disorder: a preliminary report.
Blum K; Braverman ER; Wood RC; Gill J; Li C; Chen TJ; Taub M; Montgomery AR; Sheridan PJ; Cull JG
Pharmacogenetics; 1996 Aug; 6(4):297-305. PubMed ID: 8873216
[TBL] [Abstract][Full Text] [Related]
10. Generational association studies of dopaminergic genes in reward deficiency syndrome (RDS) subjects: selecting appropriate phenotypes for reward dependence behaviors.
Blum K; Chen AL; Oscar-Berman M; Chen TJ; Lubar J; White N; Lubar J; Bowirrat A; Braverman E; Schoolfield J; Waite RL; Downs BW; Madigan M; Comings DE; Davis C; Kerner MM; Knopf J; Palomo T; Giordano JJ; Morse SA; Fornari F; Barh D; Femino J; Bailey JA
Int J Environ Res Public Health; 2011 Dec; 8(12):4425-59. PubMed ID: 22408582
[TBL] [Abstract][Full Text] [Related]
11. Biotechnical development of genetic addiction risk score (GARS) and selective evidence for inclusion of polymorphic allelic risk in substance use disorder (SUD).
Blum K; Bowirrat A; Baron D; Lott L; Ponce JV; Brewer R; Siwicki D; Boyett B; Gondre-Lewis MC; Smith DE; Panayotis K T; Badgaiyan S; Hauser M; Fried L; A R; Downs BW; Badgaiyan RD
J Syst Integr Neurosci; 2020 Aug; 6(2):. PubMed ID: 33614164
[TBL] [Abstract][Full Text] [Related]
12. The Benefits of Genetic Addiction Risk Score (GARS
Blum K; Modestino EJ; Gondre-Lewis M; Chapman EJ; Neary J; Siwicki D; Baron D; Hauser M; Smith DE; Roy AK; Thanos PK; Steinberg B; McLaughlin T; Fried L; Barh D; Dunston GA; Badgaiyan RD
Int J Genom Data Min; 2018; 2018(1):. PubMed ID: 30198022
[TBL] [Abstract][Full Text] [Related]
13. Theorizing the Role of Dopaminergic Polymorphic Risk Alleles with Intermittent Explosive Disorder (IED), Violent/Aggressive Behavior and Addiction: Justification of Genetic Addiction Risk Severity (GARS) Testing.
Modestino EJ; Blum K; Dennen CA; Downs BW; Bagchi D; Llanos-Gomez L; Elman I; Baron D; Thanos PK; Badgaiyan RD; Braverman ER; Gupta A; Gold MS; Bowirrat A
J Pers Med; 2022 Nov; 12(12):. PubMed ID: 36556167
[TBL] [Abstract][Full Text] [Related]
14. Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry?
Blum K; Dennen CA; Elman I; Bowirrat A; Thanos PK; Badgaiyan RD; Downs BW; Bagchi D; Baron D; Braverman ER; Gupta A; Green R; McLaughlin T; Barh D; Gold MS
J Pers Med; 2022 Oct; 12(10):. PubMed ID: 36294858
[TBL] [Abstract][Full Text] [Related]
15. Coupling Neurogenetics (GARS™) and a Nutrigenomic Based Dopaminergic Agonist to Treat Reward Deficiency Syndrome (RDS): Targeting Polymorphic Reward Genes for Carbohydrate Addiction Algorithms.
Blum K; Simpatico T; Badgaiyan RD; Demetrovics Z; Fratantonio J; Agan G; Febo M; Gold MS
J Reward Defic Syndr; 2015; 1(2):75-80. PubMed ID: 27617300
[TBL] [Abstract][Full Text] [Related]
16. Hypothesizing dopaminergic genetic antecedents in schizophrenia and substance seeking behavior.
Blum K; Oscar-Berman M; Badgaiyan RD; Palomo T; Gold MS
Med Hypotheses; 2014 May; 82(5):606-14. PubMed ID: 24636783
[TBL] [Abstract][Full Text] [Related]
17. The taqI DRD2 A1 allele is associated with alcohol-dependence although its effect size is small.
Berggren U; Fahlke C; Aronsson E; Karanti A; Eriksson M; Blennow K; Thelle D; Zetterberg H; Balldin J
Alcohol Alcohol; 2006; 41(5):479-85. PubMed ID: 16751215
[TBL] [Abstract][Full Text] [Related]
18. Genetic Addiction Risk Severity Assessment Identifies Polymorphic Reward Genes as Antecedents to Reward Deficiency Syndrome (RDS) Hypodopaminergia's Effect on Addictive and Non-Addictive Behaviors in a Nuclear Family.
Dennen CA; Blum K; Bowirrat A; Thanos PK; Elman I; Ceccanti M; Badgaiyan RD; McLaughlin T; Gupta A; Bajaj A; Baron D; Downs BW; Bagchi D; Gold MS
J Pers Med; 2022 Nov; 12(11):. PubMed ID: 36579592
[TBL] [Abstract][Full Text] [Related]
19. Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART).
Blum K; Chen TJ; Downs BW; Bowirrat A; Waite RL; Braverman ER; Madigan M; Oscar-Berman M; DiNubile N; Stice E; Giordano J; Morse S; Gold M
Postgrad Med; 2009 Nov; 121(6):176-96. PubMed ID: 19940429
[TBL] [Abstract][Full Text] [Related]
20. Associations of the DRD2 TaqIA polymorphism with impulsivity and substance use: preliminary results from a clinical sample of adolescents.
Esposito-Smythers C; Spirito A; Rizzo C; McGeary JE; Knopik VS
Pharmacol Biochem Behav; 2009 Sep; 93(3):306-12. PubMed ID: 19344737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
